Cell-cycle dysregulation and anticancer therapy
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (3) , 139-145
- https://doi.org/10.1016/s0165-6147(03)00026-9
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Cell cycle checkpoint signaling through the ATM and ATR kinasesGenes & Development, 2001
- Checking out the G2/M transitionBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2001
- The Retinoblastoma Gene: A Prototypic and Multifunctional Tumor SuppressorExperimental Cell Research, 2001
- p53 Signaling and Cell Cycle CheckpointsChemical Research in Toxicology, 2001
- p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein DependentMolecular and Cellular Biology, 2000
- The Physiology of p16INK4A-Mediated G1 Proliferative ArrestCell Biochemistry and Biophysics, 2000
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- How the Cyclin Became a Cyclin: Regulated Proteolysis in the Cell CycleCell, 1999
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- When Checkpoints FailCell, 1997